We performed a phenotypic screen focusing on antiproliferative agents in parallel with a gene-expression-based screen approach to identify molecules that impair cell proliferation by suppressing an EVI1 signature (Fig. 1A) in AML cells overexpressing EVI1 (EVI1High). This evidence concerns the gene MECOM and acute myeloid leukemia.